Home Applications 070947 Application 070947
Type ANDA
Sponsor MYLAN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE TABLET;ORAL 25MG;80MG No Yes 002 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE TABLET;ORAL 25MG;40MG No Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A070947-001 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE 25MG;80MG TABLET / ORAL 1987-04-01 A070947-002 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE 25MG;40MG TABLET / ORAL 1987-03-04
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 A070947-001 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;80MG TABLET / ORAL 1987-04-01 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A070947-002 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL 1987-03-04 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A070947-001 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;80MG TABLET / ORAL 1987-04-01 e64feba35796…2022-09-29 23:25 UTC 2022-09 A070947-002 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL 1987-03-04 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A070947-001 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;80MG TABLET / ORAL 1987-04-01 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A070947-002 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL 1987-03-04 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A070947-001 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;80MG TABLET / ORAL 1987-04-01 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A070947-002 PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL 1987-03-04 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0378-0347 Propranolol Hydrochloride and Hydrochlorothiazide propranolol hydrochloride and hydrochlorothiazide Mylan Pharmaceuticals Inc. ANDA Current 0378-0347 Propranolol Hydrochloride and Hydrochlorothiazide propranolol hydrochloride and hydrochlorothiazide Mylan Pharmaceuticals Inc. ANDA Current 0378-0731 Propranolol Hydrochloride and Hydrochlorothiazide propranolol hydrochloride and hydrochlorothiazide Mylan Pharmaceuticals Inc. ANDA Current 0378-0731 Propranolol Hydrochloride and Hydrochlorothiazide propranolol hydrochloride and hydrochlorothiazide Mylan Pharmaceuticals Inc. ANDA Current